As used in this chapter of the Administrative Code:
(A) "The board" means the state medical board of Ohio.
(B) "ODH" means the Ohio department of health.
(C) "HIV" means the human immunodeficiency virus.
(D) "HBV" means the hepatitis B virus with hepatitis E-antigen positive status.
(E) "Licensee" means any person holding or practicing pursuant to a certificate issued by the board under Chapter 4730., 4731., 4760., 4762., or 4774. of the Revised Code.
(F) "Invasive procedure" means any of the following:
(1) Any surgical or procedural entry into tissues, cavities, or organs or repair of major traumatic injuries associated with any of the following: an operating or delivery room, emergency department, or outpatient setting, including physicians' offices; cardiac catheterization and angiographic procedures; a vaginal or cesarean delivery or other invasive obstetric procedure during which bleeding may occur; or the manipulation, cutting, or removal of any oral or premolar tissues, including tooth structure, during which bleeding occurs or the potential for bleeding exists.
(2) Any entry into the hair follicle using an electric modality for the purpose of hair removal:
(3) The practice of acupuncture as defined in section 4762.01 of the Revised Code:
(4) The performance of fluoroscopic procedures pursuant to section 4774.08 of the Revised Code.
(G) "Exposure-prone invasive procedures" means an invasive procedure in which there is a significant risk of contact between the blood or body fluids of the licensee and the blood or body fluids of the patient.
(1) Some characteristics of exposure prone invasive procedures include digital palpation of a needle tip in a body cavity or the simultaneous presence of the licensee's fingers and a needle or other sharp instrument or object in a poorly visualized or highly confined anatomic site.
(2) An invasive procedure is exposure prone if it presents a recognized risk of percutaneous injury to the licensee, and, in the event such an injury occurs, the licensee's blood is likely to contact the patient's body cavity, subcutaneous tissues or mucous membranes.
R.C. 119.032 review dates: 11/16/2009 and 03/31/2015
Promulgated Under: 119.03
Statutory Authority: 4730.07, 4731.05, 4760.19, 4762.19, 4774.11
Rule Amplifies: 4730.25, 4731.051, 4731.22, 4731.224, 4760.13, 4762.13, 4774.13
Prior Effective Dates: 7/31/96, 9/22/97, 2/28/04